CoChat

Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma

Open access
Moreau, Philippe, Kolb, Brigitte, Attal, Michel, Caillot, Denis, Benboubker, Lotfi, Tiab, Mourad, Touzeau, Cyrille, Leleu, Xavier, Roussel, Murielle, Chaleteix, Carine, Planche, Lucie, Chiffoleau, Anne, Fortin, June, Avet-Loiseau, Hervé, Mary, Jean-Yves, Hulin, Cyrille, Facon, Thierry · 2015 · Blood
Cited by 51

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Key Points: CMP is an effective induction regimen for transplant-ineligible MM patients. The CMP regimen is safe and well tolerated with a notable lack of peripheral neuropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2015-02-626168

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 51

Metadata

Authors
Moreau, P., Kolb, B., Attal, M., Caillot, D., Benboubker, L., Tiab, M., Touzeau, C., Leleu, X., Roussel, M., Chaleteix, C., Planche, L., Chiffoleau, A., Fortin, J., Avet-Loiseau, H., Mary, J.-Y., Hulin, C., & Facon, T.
Venue
Blood
Published
2015-05-14
Volume
125
Issue
20
Pages
3100-3104
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1973621728
Cited by
51
References
6
FWCI
6.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2015-02-626168
The paper
Moreau, P., Kolb, B., Attal, M., Caillot, D., Benboubker, L., Tiab, M., Touzeau, C., Leleu, X., Roussel, M., Chaleteix, C., Planche, L., Chiffoleau, A., Fortin, J., Avet-Loiseau, H., Mary, J.-Y., Hulin, C., & Facon, T. (2015). Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma. Blood. https://doi.org/10.1182/blood-2015-02-626168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.